GSK's ViiV seeks marketing license for baby-friendly HIV pill

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 49 sec. here
  • 2 min. at publisher
  • 📊 Qulity Score:
  • News: 23%
  • Publisher: 66%

British drugmaker GSK applied on Friday for a license to market its HIV drug dolutegravir in a formulation designed to be easier for babies and ...

Singapore Headlines News

Singapore Latest News, Singapore Headlines

LONDON: British drugmaker GSK applied on Friday for a license to market its HIV drug dolutegravir in a formulation designed to be easier for babies and children who are living with the virus to swallow.

Doctors wanting to use dolutegravir in children with HIV have had no licensed child formulations, meaning they often must prescribe older HIV medicines that can be less potent, harder for children to take, and have more side effects. "We're hopeful this submission will enable approval of dolutegravir across the pediatric spectrum and allow them to have access to the preferred treatment option," she told Reuters.Doluetragravir is a so-called integrase inhibitor and was originally developed by ViiV, in which Pfizer Inc and Shionogi & Co have small stakes. For the adult formulation, ViiV has already agreed licensing deals with generic companies to sell low-cost versions in poor countries.

Helen McDowell, ViiV's head of government affairs and global public health, said that subject to licenses being granted by U.S. and European drug regulators, the company was planning for an initial roll-out in sub-Saharn Africa next year.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in SG
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

MAS revokes capital markets licence of investment firm CT Bright InvestmentSINGAPORE: The Monetary Authority of Singapore (MAS) announced on Thursday (Dec 12) that it has revoked the Capital Markets Services Licence of CT ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Cabby on girlfriend's medication lost control of vehicle, crashed into motorcyclist who diedSINGAPORE: A taxi driver who took his girlfriend's pills and some cough syrup for a headache drove dangerously and lost control of his vehicle, ... He took in so many medicine, and still driving. No wonder.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

SingSaver gets MAS brokerage licence to offer insurance comparisons on platformRead more at The Business Times.
Source: BusinessTimes - 🏆 15. / 51 Read more »

MAS pulls CT Bright Investment's licence to conduct fund management businessSINGAPORE (THE BUSINESS TIMES) - CT Bright Investment (CTBI) is no longer allowed to continue its fund management business in Singapore after the Monetary Authority of Singapore (MAS) revoked its capital markets services licence with effect from Dec 9.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »

SingSaver gets licence to offer instant comparisons of insurance products onlineSINGAPORE (THE BUSINESS TIMES) - Financial comparison platform SingSaver has secured a brokerage licence from the Monetary Authority of Singapore (MAS) to offer over 100 insurance policies from 12 providers on its platform.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »

Nokia says Daimler, others agreed to mediation to resolve licensing disputeNokia on Thursday said that German carmaker Daimler and several car parts suppliers have agreed to independent mediation to resolve their ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »